Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

PDSBPDSB
Showing 7 of 20 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in PDS BIOTECHNOLOGY CORP

CITADEL ADVISORS LLC holds 323,801 shares of PDSB (PDS BIOTECHNOLOGY CORP), worth $285,301 as of 2026-Q2. This is a new position.

Current Value

$285,301

Current Shares

323,801

Total Value Change

-$153,930

Total Shares Change

+208,819

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
323,801
-
$285,3010.0%$0.88
36
2025-Q4
Exited
0
-100.0%
$00.0%$0.80
0
2025-Q3
Increased
386,430
+55.2%
$390,2940.0%$1.01
34
2025-Q2
New
249,025
-
$331,2030.0%$1.41
33
2025-Q1
Exited
0
-100.0%
$00.0%$1.26
0
2024-Q4
Increased
220,215
+91.5%
$358,9500.0%$1.69
37
2024-Q3
Increased
114,982
+136.1%
$439,2310.0%$3.37
39

Other major holders of PDSB: BlackRock Finance, Inc., TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used